TRIM9, a novel brain-specific E3 ubiquitin ligase, is repressed in the brain of Parkinson's disease and dementia with Lewy bodies

by Kunikazu Tanji, Tetsu Kamitani, Fumiaki Mori, Akiyoshi Kakita, Hitoshi Takahashi, Koichi Wakabayashi
Published 2010-05-01

Lewy Body Dementias: A Coin with Two Sides?

by Ángela Milán-Tomás, Marta Fernández-Matarrubia, María Cruz Rodríguez-Oroz
Published 2021-06-01

The Impact of the COVID-19 Pandemic and Lockdown on Mild Cognitive Impairment, Alzheimer's Disease and Dementia With Lewy Bodies in China: A 1-Year Follow-Up Study

by Zhi-Chao Chen, Shuai Liu, Jinghuan Gan, Lingyun Ma, Xiaoshan Du, Han Zhu, Jiuyan Han, Junying Xu, Hao Wu, Min Fei, Yuchao Dou, Yaqi Yang, Peng Deng, Xiao-Dan Wang, Yong Ji, Yong Ji
Published 2021-07-01

Alpha-Synuclein Pathology Coincides With Increased Number of Early Stage Neural Progenitors in the Adult Hippocampus

by Hannah Bender, Simone A. Fietz, Franziska Richter, Franziska Richter, Milos Stanojlovic
Published 2021-07-01

“Semantic variant primary progressive aphasia” due to comorbidity of Lewy body disease and a previous cerebral venous infarction in the left anterior temporal lobe: A case report...

by Kazuo Kakinuma, Wataru Narita, Toru Baba, Osamu Iizuka, Yoshiyuki Nishio, Kyoko Suzuki
Published 2021-03-01

Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy

by Jacqui T. Nimmo, Ajay Verma, Jean-Cosme Dodart, Chang Yi Wang, Jimmy Savistchenko, Ronald Melki, Roxana O. Carare, James A. R. Nicoll
Published 2020-11-01

Can visuospatial measures improve the diagnosis of Alzheimer's disease?

by Shirin Salimi, Muireann Irish, David Foxe, John R. Hodges, Olivier Piguet, James R. Burrell
Published 2018-01-01

Prevalence of Dementia and Mild Cognitive Impairment in the Rural Island Town of Ama-cho, Japan

by Kenji Wada-Isoe, Yusuke Uemura, Satoko Nakashita, Mika Yamawaki, Kenichiro Tanaka, Mikie Yamamoto, Hiroshi Shimokata, Kenji Nakashima
Published 2012-04-01

The Pharmacology of Visual Hallucinations in Synucleinopathies

by Mirella Russo, Claudia Carrarini, Fedele Dono, Marianna Gabriella Rispoli, Martina Di Pietro, Vincenzo Di Stefano, Laura Ferri, Laura Bonanni, Stefano Luca Sensi, Stefano Luca Sensi, Stefano Luca Sensi, Marco Onofrj
Published 2019-12-01

Glucocerebrosidase Mutations and Synucleinopathies. Potential Role of Sterylglucosides and Relevance of Studying Both GBA1 and GBA2 Genes

by Rafael Franco, Rafael Franco, Juan A. Sánchez-Arias, Gemma Navarro, Gemma Navarro, Gemma Navarro, José L. Lanciego, José L. Lanciego, José L. Lanciego
Published 2018-06-01

Evidence That Parietal Lobe Fatty Acids May Be More Profoundly Affected in Moderate Alzheimer’s Disease (AD) Pathology Than in Severe AD Pathology

by Muhammad L. Nasaruddin, Xiaobei Pan, Bernadette McGuinness, Peter Passmore, Patrick G. Kehoe, Christian Hölscher, Stewart F. Graham, Brian D. Green
Published 2018-10-01

An Informant-Based Simple Questionnaire for Visuospatial Dysfunction Assessment in Dementia

by Ching-Tsu Wang, Guang-Uei Hung, Cheng-Yu Wei, Ray-Chang Tzeng, Pai-Yi Chiu
Published 2020-01-01

Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions

by Claudia Carrarini, Mirella Russo, Fedele Dono, Filomena Barbone, Marianna G. Rispoli, Laura Ferri, Martina Di Pietro, Anna Digiovanni, Paola Ajdinaj, Rino Speranza, Alberto Granzotto, Alberto Granzotto, Alberto Granzotto, Valerio Frazzini, Valerio Frazzini, Valerio Frazzini, Astrid Thomas, Andrea Pilotto, Andrea Pilotto, Alessandro Padovani, Marco Onofrj, Marco Onofrj, Stefano L. Sensi, Stefano L. Sensi, Laura Bonanni, Laura Bonanni
Published 2021-04-01

Differential effects of immunotherapy with antibodies targeting α-synuclein oligomers and fibrils in a transgenic model of synucleinopathy

by Omar El-Agnaf, Cassia Overk, Edward Rockenstein, Michael Mante, Jazmin Florio, Anthony Adame, Nishant Vaikath, Nour Majbour, Seung-Jae Lee, Changyoun Kim, Eliezer Masliah, Robert A. Rissman
Published 2017-08-01

Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology

by Nishant N. Vaikath, Nour K. Majbour, Katerina E. Paleologou, Mustafa T. Ardah, Esther van Dam, Wilma D.J. van de Berg, Shelley L. Forrest, Laura Parkkinen, Wei-Ping Gai, Nobutaka Hattori, Masashi Takanashi, Seung-Jae Lee, David M.A. Mann, Yuzuru Imai, Glenda M. Halliday, Jia-Yi. Li, Omar M.A. El-Agnaf
Published 2015-07-01

Alteration of autophagosomal proteins (LC3, GABARAP and GATE-16) in Lewy body disease

by Kunikazu Tanji, Fumiaki Mori, Akiyoshi Kakita, Hitoshi Takahashi, Koichi Wakabayashi
Published 2011-09-01

The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse

by Mari H. Savolainen, Christopher T. Richie, Brandon K. Harvey, Pekka T. Männistö, Kathleen A. Maguire-Zeiss, Timo T. Myöhänen
Published 2014-08-01

Glucagon-like peptide 1 (GLP-1) signaling attenuates dementia with Lewy bodies (DLB) associated neurotoxicity through restoration of insulin signaling

by Chia-Ling Hsieh, 謝佳羚
Published 2018

Motor Dysfunction Questionnaire and Dopamine Transporter Imaging Composite Scale Improve Differentiating Dementia With Lewy Bodies From Alzheimer's Disease With Motor Dysfunction

by Pai-Yi Chiu, Pai-Yi Chiu, Cheng-Yu Wei, Guang-Uei Hung, Shey-Lin Wu, Shey-Lin Wu
Published 2021-08-01

Differential diagnostic value of total alpha-synuclein assay in the cerebrospinal fluid between Alzheimer’s disease and dementia with Lewy bodies from the prodromal stage

by Olivier Bousiges, Nathalie Philippi, Thomas Lavaux, Armand Perret-Liaudet, Ingolf Lachmann, Caroline Schaeffer-Agalède, Pierre Anthony, Anne Botzung, Lucie Rauch, Barbara Jung, Paulo Loureiro de Sousa, Catherine Demuynck, Catherine Martin-Hunyadi, Benjamin Cretin, Frédéric Blanc
Published 2020-09-01